Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories
Last twist bioscience corp earnings: 2/6 04:05 pm
Check Earnings Report
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has signed an agreement enabling multiple academic laboratories at Stanford University to access Twist Bioscience’s innovative antibody discovery and optimization services as well as its unique “Library of Libraries” for biologics discovery.Through Stanford’s Innovative Medicines Accelerator (IMA), its researchers will be able to access Twist’s “Library of Libraries,” a range of pre-constructed and validated synthetic antibody libraries, as well as proprietary discovery and optimization capabilities of Twist Biopharma, a division of Twist Bioscience, to accelerate antibody discovery against a wide range of therapeutic targets.Each academic laboratory working through the IMA may independently access the “Library of Libraries” and once accessed, has the option to use this robu
[Read more]
| Impact snapshot | Event time: | TWST | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
TWST alerts
TWST alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corp news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience and Codexis in focus as Piper Sandler upbeat on synthetic biology, and more in today’s analyst action [Seeking Alpha]Seeking Alpha
- Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization SoftwareBusiness Wire
- Twist Bioscience Co. (<a href="https://www.marketbeat.com/stocks/NASDAQ/TWST/price-target/">NASDAQ: TWST</a>) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $150.00 price target on the stock.MarketBeat
- Twist Bioscience Co. (<a href="https://www.marketbeat.com/stocks/NASDAQ/TWST/price-target/">NASDAQ: TWST</a>) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.MarketBeat
- AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine TestsBusiness Wire
- More
TWST
SEC Filings
- 4/7/21 - Form 4
- 4/7/21 - Form 4
- 4/7/21 - Form 4
- TWST's page on the SEC website
- More